Compare CTKB & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | GEVO |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.1M | 568.2M |
| IPO Year | 2021 | 2010 |
| Metric | CTKB | GEVO |
|---|---|---|
| Price | $4.29 | $2.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $5.63 | ★ $6.42 |
| AVG Volume (30 Days) | 725.9K | ★ 3.8M |
| Earning Date | 05-07-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $193,015,000.00 | $711,000.00 |
| Revenue This Year | $5.42 | $19.44 |
| Revenue Next Year | $7.03 | $5.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.67 | N/A |
| 52 Week Low | $2.37 | $0.92 |
| 52 Week High | $6.18 | $2.95 |
| Indicator | CTKB | GEVO |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 67.54 |
| Support Level | $4.00 | $2.25 |
| Resistance Level | $4.51 | $2.95 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 43.13 | 92.11 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.